Komori
Human Metabolome Technologies (6090) · PolicyRestated

Change in the Allocation Basis for Corporate Expenses by Segment

First written in FY2022-Q1. 2 of 3 entries say "Restated". Latest entry: FY2022-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2022-Q32021: 120212022: 22022
Same theme, other companies
Change in the Method of Measuring Reporting Segment ProfitA theme 116 companies write about · 0 as a headwind · 19 as a tailwind

70 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 116 companies compared. The sentences above are computed from all 116.
Full recordFilings, disclosures and news, newest first
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Change in the Allocation Basis for Corporate Expenses by Segment | Human Metabolome Technologies,Inc. (6090) | Komori